1.A Urodynamic Database Management using MS Access Computer Program.
Kap Byung KIM ; Dong Woo RO ; Duk Yoon KIM
Journal of the Korean Continence Society 1999;3(1):35-40
No abstract available.
Urodynamics*
2.Correlation of the International Index of Erectile Function and Penile Vascular Status in Patients with Erectile Dysfunciton.
Byung Gi OH ; Hana YOON ; Woo Sik CHUNG
Korean Journal of Urology 2000;41(11):1379-1383
No abstract available.
Humans
3.Bilateral Wilms Tumor: A Case Report.
Gyung Woo JUNG ; Jin Han YOON ; Jong Byung YOON
Korean Journal of Urology 1987;28(3):419-422
A male child of 9 months with bilateral Wilms tumor was admitted to our hospital. His chief complaint was abdominal mass. Clinical examination and IVP, USG and CT-scan disclosed bilateral Wilms tumor. Right nephrectomy and left partial nephrectomy were performed. Anuria was experienced to 24 hours and so exploratory-laparotomy was done. Renal autotranplantation was performed because of the thrombosis of renal artery. But six days after operation he died.
Anuria
;
Child
;
Humans
;
Male
;
Nephrectomy
;
Renal Artery
;
Thrombosis
;
Wilms Tumor*
4.Studies on the Association between Phenylpropanolamine (PPA) and Hemorrhagic Stroke in Other Countries.
Seung Mi LEE ; Byung Woo YOON ; Byung Joo PARK
Korean Journal of Epidemiology 2004;26(2):1-7
OBJECTIVES: Phenylpropanolamine (PPA) had been used widely as cold remedies or appetite suppressants. However, products containing PPA were withdrawn in sequence in the US, Japan, and Korea due to the increased risk of hemorrhagic stroke. The purpose of this paper was to review safety issues related with the PPA use and hemorrhagic stroke in view of pharmacoepidemiology and pharmacovigilance. METHODS AND MATERIALS: Researches conducted for evaluating the association between the PPA use and hemorrhagic stroke in other countries were reviewed, which involved case reports, case series, case-control studies, and cohort studies. RESULTS: In terms of pharmacologic and clinical features, PPA may increase the risk of hemorrhagic stroke through increased blood pressure, heart rate, or vasculitis. The association between the PPA use and hemorrhagic stroke among young women was suggested by case reports from spontaneous adverse events reporting systems or medical journals. The cohort study, using the large prescription database in the US and published in 1984, failed to reveal the association in the population aged below 65. The case-control study conducted as the Yale Hemorrhagic Stroke Project, published in 2000, was the first study to find the association between the PPA as appetite suppressants and hemorrhagic stroke among women ages 18-49 years by well-designed analytic epidemiological research. It led to withdrawal of all products containing PPA in the US and many other countries since 2000. However, the association between PPA and cerebral hemorrhage could not be confirmed by the case-control study conducted in Mexico due to inappropriate recruitment of control group. CONCLUSIONS: During several years case reports have suggested that hemorrhagic stroke could be induced by PPA, and the Yale Hemorrhagic Stroke Project revealed the association by case-control study and provided a useful model for pharmacovigilance. Nevertheless, their finding could not be applied to other population such as elderly women and male population. And they could not provide any evidence on the association between PPA and stroke when PPA was used as cold remedy taken daily dose below 100mg.
Aged
;
Appetite Depressants
;
Blood Pressure
;
Case-Control Studies
;
Cerebral Hemorrhage
;
Cohort Studies
;
Female
;
Heart Rate
;
Humans
;
Japan
;
Korea
;
Male
;
Mexico
;
Pharmacoepidemiology
;
Pharmacovigilance
;
Phenylpropanolamine*
;
Prescriptions
;
Stroke*
;
Vasculitis
5.A Clinical Study of Transient Ischemic Attacks Preceding Cerebral Infarcts.
Yong Seok LEE ; Byung Woo YOON ; Jae Kyu ROH
Journal of the Korean Neurological Association 1996;14(1):9-16
Transient ischemic attack (TIA) often precede cerebral infarcts as a warning symptom. But the studies revealing the frequency and the correlation between preceding TIAs and following infarcts are rare. According to the western data, about one-quarter of the patients with cerebral infarct have been supposed to have the previous history of TIAs. We prospectively studied the exact frequency, clinical presentation, and presumed causes of TIAs preceding cerebral infarct. Ninety five patients diagnosed as acute cerebral infarction were interviewed whether they had had previous episodes of TIA. 4 check-list using ordinary language was used, and NINDS diagnostic criteria was applied on the consensus between several neurologists. Seventeen patients (18%) had history of preceding TIAs. Carotid territory was affected in 11 patients (65%), while vertebrobasilar in 4(24%) and undetermined in 2. Duration was less than an hour in 10 patients(59%), and attacks were multiple in about half. Time interval between the last attack and infarction was less than one week in 10 cases(59%). Incidence of recent TIA ((1 month) was 22% in large artery disease(LAD), 11% In cardioembolism(CE), 9% in small-artery disease(SAD), and 7% in mixed etiology. Conclusion, TIAs preceding cerebral infarcts are not rare, but seems to be less common in Koreans than in Caucasians. As expected, atherothrombosis of large artery is supposed to be the leading cause of TIAs.
Arteries
;
Cerebral Infarction
;
Consensus
;
Humans
;
Incidence
;
Infarction
;
Ischemic Attack, Transient*
;
National Institute of Neurological Disorders and Stroke
;
Prospective Studies
6.How well Do We Prevent Cardioembolic Stroke?.
Byung Woo YOON ; Byoung Kon KIM ; Jae Kyu ROH
Journal of the Korean Neurological Association 1996;14(1):1-8
BACKGROUND & OBJECTIVE: Recent studies suggest that anticoagulation, or antiplatelet therapy is safe and effective for the prevention of cardiogenic embolic stroke. However it has not been studied in Korea how the patients with cardioembolic source were managed in practice for the prevention of stroke. This study was done to assess the current status of primary and secondary prevention of cardioembolic stroke. METHODS: Retrospective study was undertaken in 124 patients with cardiogenic embolic stroke, following items were examined, previous anticoagulation or antiplatelet therapy, previous stroke, Insight of the heart disease, and International Normalize Ratio(INR) value on arrival at the hospital. RESULTS: In 124 patients cardioembolic sources were constituted of non-valvular atrial fibrillation (NVAF) in 54, rheumatic heart disease In 40, prosthetic cardiac valve In 14, dilated cardiomyopathy(D-CMP) in 6, left ventricular akinetic segment in 7(including 3 cases of LV thrombi), recent myocardial infarction in 3. In 93 patients with no previous stroke, 44 patients had regular medical follow-up because of his/her cardiac problems and primary prevention of stroke was made only in 12 (27%) patients (8 on anticoagulation and 4 on antiplatelet therapy). The rate of primary prevention varied according to the type of cardioembolic source; 100% with mechanical prosthetic valve, 33.3% with valvular atrial fibrillation, 6.7% with NVAF, and none with D-CMP and bioprosthetic valve. Previous stroke was found in 31 patients, among whom 24 had been followed regularly. Twenty patients(83%) were under secondary prevention of cardioembolic stroke (anticoagulation in 11 and antiplatelet agents in 9). Among 19 patients who developed stroke in spite of anticoagulation, INR values were lower than 1.5 in 12(63%), between 1.5 and 2.0 in 5(26%), and above 2.0 in 2(11%). CONCLUSION: Our results suggest that cardioembolic strokes have not been prevented properly. Many physicians seem to be reluctant to anticoagulate their patients with cardioembolic source, and even with anticoaguation the dosage is frequently insufficient to prevent stroke.
Atrial Fibrillation
;
Follow-Up Studies
;
Heart Diseases
;
Heart Valves
;
Humans
;
International Normalized Ratio
;
Korea
;
Myocardial Infarction
;
Platelet Aggregation Inhibitors
;
Primary Prevention
;
Retrospective Studies
;
Rheumatic Heart Disease
;
Secondary Prevention
;
Stroke*
7.A Comparison of Infarct Size and Prognosis between Cardiogenic Embolic Infarction and Large Artery Atherosclerotic Infarction.
Ji Hoon JANG ; Byung Woo YOON ; Jae Kyu ROH
Journal of the Korean Neurological Association 2000;18(4):381-385
BACKGROUND: Cardiogenic embolic infarction is the most preventable type of ischemic stroke. This study was under-taken to compare the infarct size, prognosis, and risk factors between cardiogenic embolic infarction (CE) and large artery atherosclerotic infarction (LAA). METHODS:We reviewed the medical records and brain computed tomography/magnetic resonance image (CT/MRI) scans of patients with CE or LAA during the period between January 1996 and May 1998. Patients with lacunar and posterior circulation infarctions were excluded. A slice of brain CT/MRI scan showing the largest lesion was selected in each patient and the area of infarction was then measured. Prognosis was determined by the Modified Rankin Disability Scale (MRDS) and was grouped as either good (MDRS 0, 1, 2) or poor (MDRS 3, 4, 5). RESULTS: The study included 103 patients : 50 with CE (NVAF in 23, VHD with or without AF in 13, prosthetic valve in 6, and others in 8) and 53 with LAA (large artery thrombosis in 29, and artery to artery embolism in 24). The infarct size of CE (23.2+/-14.7 cm2) was significantly larger than that of LAA (11.4+/-10.5 cm2) (p<0.001). The infarct size of NVAF (29.0+/-19.1 cm2) was significantly larger than that of VHD with or without AF (19.2+/-11.5 cm2) (p<0.05). Patients with CE had a worse prognosis (poor in 46%) than those with LAA (poor in 23%) (p<0.05). CONCLUSIONS Our results showed that CE led to larger lesions and worse outcomes. Therefore, we emphasize the importance of primary and secondary preventions of stroke in patients with cardiogenic embolic sources.
Arteries*
;
Brain
;
Embolism
;
Heart Valve Diseases
;
Humans
;
Infarction*
;
Medical Records
;
Prognosis*
;
Risk Factors
;
Secondary Prevention
;
Stroke
;
Thrombosis
8.Eye Department, National Medical Center, Korea..
Journal of the Korean Ophthalmological Society 1966;7(2):73-75
A series of 135 cases of pterygium observed at the Eye Dept. in the National Medical Center from April 1963 to May 1966, were treated with thio-tepa after the surgical removal and were studied clinically in regard to the incidence of the recurrence. Among the total series, only one case showed no response to the thio-tepa instillation and the recurrence persisted. There was a case of allergic response to the thio-tepa, which has not been found in any reports known. No serious local or systemic toxcity or any sequelae such as corneal damages, defective vision or the interference with wound healing could be observed.
Incidence
;
Korea*
;
Pterygium
;
Recurrence
;
Thiotepa
;
Wound Healing
9.Study on Urine Alkalizing Agents.
Hyun Woo KIM ; Jong Byung YOON
Korean Journal of Urology 1982;23(1):60-68
The authors investigated diurnal change of urinary pH in control group and urine alkalizing group. The control group composed of normal group and hydration group (water 2000 cc/day). The urine alkalizing agent group composed of sodium bicarbonate group (4gm/day, 6mg./day, 8gm/day and 12gm./day) and citrate agent groups (Eisenberg`s solution; 60cc/day and CG-120 or Uralyt-U;4gm./day) in 15 normal healthy adult male. The results were summarized as follows; 1. In normal control group and hydration group, diurnal urinary pH were 5.89+0.47 and 6.00 + 0.44 respectively, There was no significant difference between normal control group and hydration group (p<0.05). 2. In urine alkalizing agent foup, diurnal urinary pH of sodium bicarbicar-bonate groups (4gm./day, 6gm./day, 8gm./day and 12gm./day) were 6.26+0.51, 6.64+0.41, 6.74+0.53 and 7. 15+0.64 respectively, and diurnal urinary pH of citrate agent foups (Eisenberg`s solution and CG-120) were 7.04+0.78 and 6.48+0.60 respectively. The urinary pH was increased about 0.1 every 1gm./day addition of sodium bicarbonate. For maintenance of urinary pH between 6.2-7.0 administration 4-8gm./day of sodium bicarbonate was favorable. It was 5 times as much as CG-120 (4gm./day) in amount that Eisenberg`s solution contains 19.12gm of citrate in diurnal administration volume (60cc/day). So the augment effect of urinary pH of CG-120 was significantly great and its side effect was relatively less.
Adult
;
Citric Acid
;
Humans
;
Hydrogen-Ion Concentration
;
Male
;
Sodium
;
Sodium Bicarbonate
10.Neurologic Complications of Infective Endocarditis:Retrospective Review of 100 Cases.
Sung Hun KIM ; Jaseong KOO ; Byung Woo YOON
Journal of the Korean Neurological Association 2001;19(3):202-206
BACKGROUND: Neurological syndromes often complicate the management of infective endocarditis. METHODS: We reviewed the neurological complications in 100 patients with infective endocarditis in a tertiary care hospital. RESULTS: Neurological complications occurred in 25 patients (25%). Ischemic infarctions occurred in 15 patients, hemorrhagic infarctions in 5, intracerebral hemorrhages in 12, subarachnoid hemorrhages in 4, and subdural hemorrhages in 2. Brain abscess was detected in 4 and seizures in 2 patients. Staphylococcus aureus endocarditis (p=0.01) and mitral valvular heart disease (p=0.015) correlated statistically with the development of neurological complications. The mortality rate was significantly higher in patients with neurological complications than those without neurological complications (p=0.00). Age, sex, and type of valve (native versus prosthetic) were not related to the complication rate. CONCLUSIONS: We concluded that (1) hemorrhagic complications occurred at a higher rate in this study than previous reports; (2) S.aureus infection and mitral valvular disease predicted the occurrence of neurological complications; and (3) neurological complications were related to mortality rates. (J Korean Neurol Assoc 19(3):202~206, 2001)
Brain Abscess
;
Cerebral Hemorrhage
;
Endocarditis
;
Heart Diseases
;
Heart Valve Diseases
;
Hematoma, Subdural
;
Humans
;
Infarction
;
Mortality
;
Seizures
;
Staphylococcus aureus
;
Subarachnoid Hemorrhage
;
Tertiary Healthcare